Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Cash from Investing Activities (2023)

SELLAS Life Sciences (SLS) has disclosed Cash from Investing Activities for 4 consecutive years, with -$3.0 million as the latest value for Q3 2023.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$3.0 million in Q3 2023 year-over-year; TTM through Dec 2024 was -$3.0 million, a 0.0% change, with the full-year FY2023 number at -$5.5 million, down 22.22% from a year prior.
  • Cash from Investing Activities was -$3.0 million for Q3 2023 at SELLAS Life Sciences, down from $720000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$3.0 million in Q3 2023 to a low of -$3.0 million in Q3 2023.